Literature DB >> 15227727

Iron supplementation in experimental hyperthyroidism: effects on oxidative stress in skeletal muscle tissue.

Hakki Oktay Seymen1, Sabiha Civelek, Arzu Seven, Gunnur Yigit, Husrev Hatemi, Gulden Burcak.   

Abstract

This study was designed to investigate the effects of iron supplementation on the parameters of oxidative stress in the skeletal muscle tissue of hyperthyroidism induced rats. Hyperthyroidism was found to cause an increase in thiobarbituric acid-reactive substances (TBARS) and copper zinc superoxide dismutase (Cu, Zn SOD) activity, but decreases in the glutathione-peroxidase (GSH Px) activity and glutathione (GSH). Iron supplementation caused an increase in TBARS and a decrease in GSH. Iron supplementation in hyperthyroid rats attenuated the hyperthyroid state, but lowered the plasma ferritin level, which is considered an indicator of thyroid hormone action. Iron supplementation caused no additional increase in the TBARS in hyperthyroid rats, ameliorated the decrease in GSH content and abolished the induction of Cu, Zn SOD. Our findings suggested no increase, but a decrease, in the risk of oxidative stress in iron supplemented hyperthyroid rats. Whether supplementation of iron would have similar effects in humans should be further investigated in clinical studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15227727     DOI: 10.3349/ymj.2004.45.3.413

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  2 in total

Review 1.  Vitamin E management of oxidative damage-linked dysfunctions of hyperthyroid tissues.

Authors:  Paola Venditti; Lisa Di Stefano; Sergio Di Meo
Journal:  Cell Mol Life Sci       Date:  2012-12-20       Impact factor: 9.261

2.  Antioxidant and Protective Effects of Bupleurum falcatum on the L-Thyroxine-Induced Hyperthyroidism in Rats.

Authors:  Seong-Mo Kim; Sang-Chan Kim; In-Kwon Chung; Woo-Hyun Cheon; Sae-Kwang Ku
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-25       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.